Literature DB >> 19222427

The undesirable effects of neuromuscular blocking drugs.

C Claudius1, L H Garvey, J Viby-Mogensen.   

Abstract

Neuromuscular blocking drugs are designed to bind to the nicotinic receptor at the neuromuscular junction. However, they also interact with other acetylcholine receptors in the body. Binding to these receptors causes adverse effects that vary with the specificity for the cholinergic receptor in question. Moreover, all neuromuscular blocking drugs may cause hypersensitivity reactions. Often the symptoms are mild and self-limiting but massive histamine release can cause systematic reactions with circulatory and respiratory symptoms and signs. At the end of anaesthesia, no residual effect of a neuromuscular blocking drug should be present. However, the huge variability in response to neuromuscular blocking drugs makes it impossible to predict which patient will suffer postoperative residual curarization. This article discusses the undesirable effects of the currently available neuromuscular blocking drugs including the definitions, diagnosis and causes of hypersensitivity reactions and postoperative residual curarisation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19222427     DOI: 10.1111/j.1365-2044.2008.05866.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  15 in total

1.  Reversal of neuromuscular blockade with sugammadex in a patient with spinal muscular atrophy type III (Kugelberg-Welander syndrome).

Authors:  Hugo Vilela; João Santos; João Colaço; Eduardo Oliveira; Pedro Canas-da-Silva
Journal:  J Anesth       Date:  2011-12-25       Impact factor: 2.078

2.  Double epidural catheter technique in a patient with severe COPD undergoing major abdominal surgery: A case report.

Authors:  Christian Compagnone; Valentina Bellini; Alberto Calabrese; Mario Taddei; Elena Bignami
Journal:  Int J Surg Case Rep       Date:  2022-06-25

3.  Non-intubated thoracoscopic surgery: initial experience at a single center.

Authors:  Youngkyu Moon; Zeead M AlGhamdi; Joonpyo Jeon; Wonjung Hwang; Yunho Kim; Sook Whan Sung
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 4.  Anaphyllaxis management: Current concepts.

Authors:  Shrikant Mali; Rajesh Jambure
Journal:  Anesth Essays Res       Date:  2012 Jul-Dec

5.  Comparison of neostigmine induced reversal of vecuronium in normal weight, overweight and obese female patients.

Authors:  Shilpa Bhimasen Joshi; Ks Vasudeva Upadhyaya; M Manjuladevi
Journal:  Indian J Anaesth       Date:  2015-03

Review 6.  The Physiologically Difficult Airway.

Authors:  Jarrod M Mosier; Raj Joshi; Cameron Hypes; Garrett Pacheco; Terence Valenzuela; John C Sakles
Journal:  West J Emerg Med       Date:  2015-12-08

7.  Use of neuromuscular blockers and neostigmine for general anesthesia and its association with neuraxial blockade: A retrospective study.

Authors:  Filipe Nadir Caparica Santos; Angélica de Fátima de Assunção Braga; Fernando Eduardo Feres Junqueira; Rafaela Menezes Bezerra; Felipe Ferreira de Almeida; Franklin Sarmento da Silva Braga; Vanessa Henriques Carvalho
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

Review 8.  Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?

Authors:  David Spoerl; Haig Nigolian; Christoph Czarnetzki; Thomas Harr
Journal:  Int J Mol Sci       Date:  2017-06-07       Impact factor: 5.923

9.  Neuronal Effects of Sugammadex in combination with Rocuronium or Vecuronium.

Authors:  Martin Aldasoro; Adrian Jorda; Constanza Aldasoro; Patricia Marchio; Sol Guerra-Ojeda; Marc Gimeno-Raga; Mª Dolores Mauricio; Antonio Iradi; Elena Obrador; Jose Mª Vila; Soraya L Valles
Journal:  Int J Med Sci       Date:  2017-02-23       Impact factor: 3.738

10.  Sugammadex, a neuromuscular blockade reversal agent, causes neuronal apoptosis in primary cultures.

Authors:  José M Palanca; Diana Aguirre-Rueda; Manuel V Granell; Martin Aldasoro; Alma Garcia; Antonio Iradi; Elena Obrador; Maria Dolores Mauricio; Jose Vila; Anna Gil-Bisquert; Soraya L Valles
Journal:  Int J Med Sci       Date:  2013-08-03       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.